• Blog
  • Implantable Drug Delivery Devices Market Growth Analysis

    Implantable Drug Delivery Devices Market Growth Analysis

    Implantable Drug Delivery Devices Market Growth Analysis
    Report code - SR1482 Delivery - 2 Weeks
    Implantable Drug Delivery Devices Market Growth, Trends, Dynamics & Market Insights: 2 See more...

    Market Insights

    The Implantable Drug Delivery Devices Market is estimated to grow from USD 10.6 Billion in 2020 to USD 16.7 Billion by 2026 at a healthy CAGR of 8.0% during the forecast period.

    Wish to get a free sample? Register Here

    What are implantable drug delivery devices?

    Implantable drug delivery devices are referred to the medical devices that enable site-specific drug administration. It also enables minimizing doses of the drug to reduce potential side effects. These devices facilitate the sustained release of a therapeutic agent. These implantable devices are gaining popularity over conventional oral or parenteral dosage forms, due to site-specific and sustained release therapeutic action of implantable devices, which further reduces the side effects associated with the drug.

    Implantable Drug Delivery Devices Market Report Overview

    Market Size in 2026

    USD 16.7 Billion

    Market Size in 2020

    USD 10.6 Billion

    Market Growth (2021-2026)

    CAGR of 8.0%

    Base Year of Study

    2020

    Trend Period

    2016-2019

    Forecast Period

    2021-2026

    Key Players

    Key players operating in the implantable drug delivery devices market are-

    • Allergan PLC (UK)
    • Boston Scientific Corporation (US)
    • Bausch and Lomb Inc. (Canada)
    • Medtronic PLC (UK)
    • Alcon Inc. (Switzerland)
    • Teleflex Incorporated (US)
    • DSM Biomedical (Netherlands)
    • Delpor Inc. (US)
    • 3M Company (US)

    Market Dynamics

    The growth of the implantable drug delivery devices market is propelled by a surge in the prevalence of chronic diseases around the world, a rise in demand for minimally invasive drug delivery devices, and unwanted pregnancies over some time. Moreover, strong collaboration activities among leading players are anticipated to offer lucrative growth opportunities for the implantable drug delivery devices market. However, the possibility of implanted device failures as well as stringent government regulations is likely to hamper the industry growth.

    COVID-19 Impact

    The COVID-19 outbreak positively influenced the growth of the implantable drug delivery devices market. Also, to protect the population from coronavirus infection, people should keep away from all containment zones including hospitals. This can be possible by implanting drug delivery devices in patients, which offers the advantage of not personally visiting hospitals for follow-ups or treatment procedures as implantable drug delivery devices provide long-term drug delivery. Therefore, the COVID-19 pandemic is likely to augment the implantable drug delivery devices market growth during the review period.

    To get the full scope of the report, Register Here

    Segment Analysis

    Application Trends

    The market has been classified into contraception, ophthalmology, cardiovascular, diabetes, oncology, autoimmune diseases, and others. The cardiovascular segment accounted for a substantial market share in 2020. This is mainly attributed to an increase in the patient population suffering from cardiovascular diseases, which boosts the clinical urgency to develop advanced devices. As a result, global players have developed bioabsorbable stents which are gradually absorbed and excreted by the body, further bolstering the segment growth.

    Regional Analysis

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, the strong prevalence of cardiovascular diseases, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, and extensive new development activities, further proliferate the regional growth.

    To know which region offers the best growth opportunities, Register Here

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Implantable Drug Delivery Devices Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The implantable drug delivery devices market is expected to witness an impressive growth of 8.0% CAGR in the coming years.

    Allergan PLC (UK), Boston Scientific Corporation (US), Bausch and Lomb Inc. (Canada), Med-tronic PLC (UK), Alcon Inc. (Switzerland), Teleflex Incorporated (US), DSM Biomedical (Nether-lands), Delpor Inc. (US), and 3M Company (US) are among the key players in the implantable drug delivery devices market.

    The implantable drug delivery devices market size is expected to reach USD 16.7 billion in the foreseeable future.

    The cardiovascular segment accounted for the substantial share in the implantable drug delivery devices market in 2020.

    North America is expected to remain dominant in the implantable drug delivery devices market in the next five years.

    The growth of the implantable drug delivery devices market is propelled by a surge in the prevalence of chronic diseases around the world, a rise in demand for minimally invasive drug delivery devices, and unwanted pregnancies over some time. Moreover, strong collaboration activities among leading players are anticipated to offer lucrative growth opportunities for the implantable drug delivery devices market.